MS

Michael Silberberg

Mr Silberberg is currently the Global Therapeutic Area Head, Facial Aesthetics for AbbVie, based in England. Prior to that he spent nine years working for Allergan in a variety of senior roles, culminating as Executive Medical Director, Aesthetics, International and Global Plastic Surgery Therapeutic Area Lead after starting as Director, Medical Affairs, Australia/NZ.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
25/10/240N/A392,753N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
13/11/23
Issued
392,753$0.245$96,224Issue of options